← Back to Search

Local Anesthetic

Local Anesthetics Bupivacaine for Carpal Tunnel Syndrome

N/A
Waitlist Available
Led By David Sauder, MD
Research Sponsored by University of Saskatchewan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after second surgery
Awards & highlights

Study Summary

This trial is being done to see if a longer-acting local anesthetic decreases post-operative pain after carpal tunnel release.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-operative (immediately before surgery), 3 months after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-operative (immediately before surgery), 3 months after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-operative analgesia
Post-operative pain
Secondary outcome measures
Post-operative numbness
Preference of anesthetic type
Symptom change at 3 months

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BupivacaineExperimental Treatment1 Intervention
Administration of subcutaneous bupivacaine + lidocaine as local anesthetic prior to carpal tunnel release (bupivacaine intervention)
Group II: LidocaineActive Control1 Intervention
Administration of subcutaneous lidocaine as local anesthetic prior to carpal tunnel release (lidocaine intervention)

Find a Location

Who is running the clinical trial?

University of SaskatchewanLead Sponsor
249 Previous Clinical Trials
154,034 Total Patients Enrolled
1 Trials studying Carpal Tunnel Syndrome
82 Patients Enrolled for Carpal Tunnel Syndrome
Saskatoon City HospitalOTHER
1 Previous Clinical Trials
1,200 Total Patients Enrolled
David Sauder, MDPrincipal InvestigatorUniversity of Saskatchewan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are part of this research endeavor?

"Affirmative. According to clinicaltrials.gov, this medical investigation is actively seeking participants; it was initially posted on July 1st 2021 and has since been updated on the 10th of that month. The protocol needs 140 people from a single site in order to be completed successfully."

Answered by AI

How is Bupivacaine typically utilized to bring about pain relief?

"Standardly, bupivacaine is administered to address minor burns. However, it has been shown to provide relief for lupus erythematosus cell and ulcerative colitis in addition to post-transplantation care."

Answered by AI

Is there availability for any additional participants in this experiment?

"Data available via clinicaltrials.gov confirms that this trial is actively seeking participants, with the primary listing created on July 1st 2021 and last updated a few days later on July 10th 2021."

Answered by AI

Are there any existing records of experiments that explore the uses of Local Anesthetics Bupivacaine?

"Currently, 216 clinical trials are underway that explore the effects of Bupivacaine Local Anesthetics. Of those studies, 48 have reached Phase 3 and most of them take place in Germantown, Tennessee; however there are over a thousand sites hosting these tests around the world."

Answered by AI
~38 spots leftby Mar 2025